(P037) Impact of Serial DWI and ADC Measurements in Assessment of Brain Metastases Treated With Neurosurgical Resection and Intraoperative Cesium- 131 Brachytherapy: Results of a Prospective Trial

Publication
Article
OncologyOncology Vol 28 No 1S
Volume 28
Issue 1S

Intraoperative Cs-131 brachytherapy has been demonstrated to be safe, well tolerated, and convenient for patients, rendering high local control and minimal toxicity for patients with brain metastases. In this study, we reviewed serial magnetic resonance imaging (MRI) images along with diffusion-weighted images (DWIs) for distinct local changes and assessed their clinical relevance and measured apparent diffusion coefficient (ADC) values.

Menachem Z. Yondorf, BS, A. Gabriella Wernicke, MD, MSc, Bhupesh Parashar, MD, Theodore H. Schwartz, MD, John A. Boockvar, MD, Phillip Stieg, MD, Susan Pannullo, MD, Dattatreyudu Nori, MD, K.S. Clifford Chao, MD, Ilhami Kovanlikaya, MD; Weill Cornell Medical College

Background and Objectives: Intraoperative Cs-131 brachytherapy has been demonstrated to be safe, well tolerated, and convenient for patients, rendering high local control and minimal toxicity for patients with brain metastases (Wernicke et al.). Early identification of residual or recurrent metastasis is crucial to apply potentially more effective therapy. Interpretation of conventional magnetic resonance imaging (MRI) is a challenge in differentiating residual tumor and possible inflammatory reactions. In this study, we reviewed serial MRI images along with diffusion-weighted images (DWIs) for distinct local changes and assessed their clinical relevance and measured apparent diffusion coefficient (ADC) values.

Materials and Methods: As part of the institutional review board (IRB)-approved prospective study, 26 patients with brain metastases treated with Cs-131 brachytherapy were evaluated with MRI exams, which included: T2-weighted, flair, diffusion-weighted, gradient recalled echo (GRE), or susceptibility weighted imaging (SWI); and T1-weighted sequences with and without contrast, before and after the surgery (the first within 48 hours and subsequent ones every 4–8 weeks). GRE/SWI images were used to rule out hemorrhage or other sources of susceptibility artifacts that cause high signal intensities on DWI. ADC values were measured and normalized by dividing contralateral normal-appearing brain parenchyma.

Results: On follow-up MRI, delayed enhancement was seen in previously ADC low areas immediately postoperatively and was interpreted as ischemic/inflammatory changes due to surgical trauma. Depending on its size and localization, some of these changes ended up as encephalomalacia in the brain parenchyma. Contrast enhancement (CE) in lower ADC areas other than the previously low ADC should be considered suspicious for a local recurrent tumor (there have been no cases of local recurrent tumor).
There were nine cases that showed increased enhancement 4–7 weeks after implantation, with higher ADC values other than surgical changes in the parenchyma around the cavity. The enhancement pattern was mostly rim-shaped, but some nodular pattern was noticed. These cases were interpreted as being suspected for recurrent tumor, and follow-up MRI was recommended. Mean ADC ratio was 1.71 (range: 1.46–1.78). In all cases, CE revealed decreased enhancement in the follow-up exams, with higher ADC values. We propose that this enhancement pattern with high ADC values is due to the inflammatory effects of Cs-131 seeds in the cavity. All of the higher ADC values seen due to surgical trauma decreased on the follow-up exams. New restricted diffusion was found in two patients: one with an abscess in the cavity and one with an additional subdural metastasis in the surgical incision. T2 hyperintensities, which reflected vasogenic edema around the metastatic tumor, decreased in 24/26 cases, mostly in 4 weeks after surgery. In two cases, T2 hyperintensities increased in the follow-up studies due to additional metastasis close to the region of original metastasis.

Conclusion: Serial DWI and measurement of ADC values on brain metastasis treated with surgical removal and brachytherapy might be very useful in differentiating ischemic necrotic inflammatory processes from residual or local recurrent neoplasms. A new enhancement observed around the surgical cavity after brachytherapy should be interpreted in the context of the serial DWIs, including preoperative evaluation.

Articles in this issue

(P113) Age and Marital Status Are Associated With Choice of Mastectomy in Patients Eligible for Breast Conservation Therapy
(P112) Single-Institution Experience With Intrabeam IORT for Treatment of Early-Stage Breast Cancer
(P110) Breast Cancer Before Age 40: Current Patterns in Clinical Presentation and Local Management
(P111) Accelerated Partial-Breast Irradiation With Multicatheter High-Dose-Rate Brachytherapy: Feasibility and Results in a Private Practice Cohort
(P115) Breast Cancer Laterality Does Not Influence Overall Survival in a Large Modern Cohort: Implications for Radiation-Related Cardiac Mortality
(P117) Anatomical Variations and Radiation Technique for Breast Cancer
(P116) Bilateral Immediate DIEP Reconstruction and Postmastectomy Radiotherapy: Experience at a Tertiary Care Institution
(P118) Metadherin Overexpression Is Associated With Improved Locoregional Control After Mastectomy
(P119) Effect of Economic Environment on Use of Postlumpectomy Radiation Therapy for Stage I Breast Cancer
(P120) Immediate Versus Delayed Reconstruction After Mastectomy in the United States Medicare Breast Cancer Patient
(P121) Trend in Age and Racial Disparities in the Receipt of Postlumpectomy Radiation Therapy for Stage I Breast Cancer: 2004–2009
(P122) Streamlining Referring Physicians Orders With ‘Reflex Testing’ Significantly Decreases Time to Resolution for Abnormal Screening Mammograms
(P123) National Trends in the Local Management of Early-Stage Paget Disease of the Breast
(P124) Effect of Inhomogeneity on Cardiac and Lung Dose in Partial-Breast Irradiation Using HDR Brachytherapy
(P125) Breast Cancer Outcomes With Anthracycline-Based Chemotherapy for Residual Disease Burden After Full-Dose Neoadjuvant Chemotherapy and Surgery Followed by Radiation Treatment
Related Videos
Pegulicianine-guided breast cancer surgery may allow practices to de-escalate subsequent radiotherapy, says Barbara Smith, MD, PhD.
Adrienne Bruce Shannon, MD, discussed ways to improve treatment and surgical outcomes for patients with dMMR gastroesophageal cancer.
Barbara Smith, MD, PhD, spoke about the potential use of pegulicianine-guided breast cancer surgery based on reports from the phase 3 INSITE trial.
Patient-reported symptoms following surgery appear to improve with the use of perioperative telemonitoring, says Kelly M. Mahuron, MD.
Treatment options in the refractory setting must improve for patients with resected colorectal cancer peritoneal metastasis, says Muhammad Talha Waheed, MD.
Although immature, overall survival data from the KEYNOTE-868 trial may support the use of pembrolizumab plus chemotherapy in patients with endometrial cancer.
Dostarlimab plus chemotherapy appears to yield favorable overall survival in patients with mismatch repair proficient endometrial cancer.
Some patients with large B-cell lymphoma may have to travel a great distance for an initial evaluation for CAR T-cell therapy.
Brian Slomovitz, MD, MS, FACOG discusses the use of new antibody drug conjugates for treating patients with various gynecologic cancers.
Education is essential to referring oncologists manage toxicities associated with CAR T-cell therapy for patients with large B-cell lymphoma.
Related Content